TeraView earns MHRA approval to conduct in-vivo clinical trials for cancer imaging

Terahertz solutions and technology manufacturer TeraView (Cambridge, England) has received approval by the Medicines and Healthcare products Regulatory Agency (MHRA; London, England) to conduct in-vivo clinical trials for cancer research using the company's Terahertz Pulsed Imaging (TPI).

The trial will focus on using terahertz imaging--which enables high-resolution subsurface imaging of tissue--as an intra-operative probe for detecting cancerous tissue during breast cancer surgery. If successful, the trial will help surgeons better identify and enable accurate removal of cancer tissue in the breast and, in turn, reduce second operation rates and improve clinical outcomes as well as reduce costs.

Terahertz imaging couples macroscopic and microscopic imaging to enable precise margin delineation of cancerous tissue. Due in part to its ability to recognize spectral fingerprints, it provides contrast between different types of soft tissue and detects the degree of water content and other cancer markers. The company's TPI software can convert these molecular markers into 3D images and aid surgeons in differentiating between cancerous and non-cancerous tissues.

With support of the TSB and in collaboration with surgeons at Guy’s Hospital, TeraView has developed a handheld device as part of the world’s first commercial terahertz medical unit. This research unit is capable of imaging a wide range of tissues and is designed to allow developments to move seamlessly through in-vitro, ex-vivo, and into in-vivo studies.

-----

Follow us on Twitter, 'like' us on Facebook, and join our group on LinkedIn

Follow Laser Focus World on your iPhone or Android

Subscribe now to BioOptics World magazine; it's free!

Get All the BioOptics World News Delivered to Your Inbox

Subscribe to BioOptics World Magazine or email newsletter today at no cost and receive the latest news and information.

 Subscribe Now
Related Articles

FDA authorizes emergency use of Zika virus molecular detection assay

The xMAP MultiFLEX Zika RNA assay combines optofluidics and digital signal processing to detect Zika virus in vitro.

Merz acquires laser tattoo removal device maker ON Light Sciences

Merz North America has acquired ON Light Sciences, which develops technologies to enhance laser-based dermatology procedures.

Shortwave-infrared device could improve ear infection diagnosis

An otoscope-like device that could improve ear infection diagnosis uses shortwave-infrared light instead of visible light.

Laser therapy extracts rare tumor that grew human hair, skin in boy's skull

About four years ago, a tumor comprised of human skin, hair, bone and cartilage was fast-growing inside a Ramsey, MN, 10-year-old youth's brain.
BLOGS

Neuro15 exhibitors meet exacting demands: Part 2

Increasingly, neuroscientists are working with researchers in disciplines such as chemistry and p...

Why be free?

A successful career contributed to keeping OpticalRayTracer—an optical design software program—fr...

LASER Munich 2015 is bio-bent

LASER World of Photonics 2015 included the European Conferences on Biomedical Optics among its si...

White Papers

Understanding Optical Filters

Optical filters can be used to attenuate or enhance an image, transmit or reflect specific wavele...

How can I find the right digital camera for my microscopy application?

Nowadays, image processing is found in a wide range of optical microscopy applications. Examples ...

CONNECT WITH US

            

Twitter- BioOptics World

Copyright © 2007-2016. PennWell Corporation, Tulsa, OK. All Rights Reserved.PRIVACY POLICY | TERMS AND CONDITIONS